Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Capecitabine × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 18 Stomach Neoplasms 11 Adenocarcinoma Of Esophagus 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Rectal Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Colonic Neoplasms 3 Adenocarcinoma 3 Pathologic Complete Response 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Gallbladder Neoplasms 2 Cholangiocarcinoma 2 Anus Neoplasms 2 Somatostatinoma 1 Resectable Colon Cancer 1 Recurrence 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Locally Advanced Rectal Cancer With Liver Metastases 1 Locally Advanced Rectal Cancer 1 Klatskin Tumor 1 Insulinoma 1 HIV Infections 1 HER2-positive Gastric Cancer 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Radiosurgery 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡